# GlycanAge

GlycanAge IgG糖基化检测 — HPLC糖链定量分析，约2万人验证研究（2026年）.

Source: https://cn.bioecon.ru/companies/glycanage/
Updated: 2026-08-15

- 国家: United Kingdom

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2025 年 12 月由 Fifth Quarter Ventures 领投的 €740 万（US$870 万） | https://agetechworld.co.uk/news/interview-glycanage-launch-first-hospital-based-tests/, https://en.lider.media/2025/12/19/croatian-glycanage-receives-new-investment-of-e8-7-million/, https://parsers.vc/news/251219-glycanage-secures-major-funding--reshaping/, https://www.eu-startups.com/2025/12/uk-longevity-startup-glycanage-raises-e7-4-million-to-bring-glycan-based-ageing-diagnostics-into-mainstream-healthcare/ |
| 融资 | 已获得超过4000万欧元的研发资助资金 | https://glycanage.com/resources/investors, https://parsers.vc/news/251219-glycanage-secures-major-funding--reshaping/ |
| 员工人数 | 员工人数在30至45人以上 | https://en.lider.media/2025/12/19/croatian-glycanage-receives-new-investment-of-e8-7-million/, https://parsers.vc/news/251219-glycanage-secures-major-funding--reshaping/ |
| 营收 | 未来十二个月(NTM)营收$620万 [中等置信度] | https://www.impetus.capital/glycanage-pioneering-preventative-healthcare-through-glycobiology/ |
| 监管批准 | 在美国利用CLIA认证实验室路径开展实验室自建检测（LDT），在欧洲正推进IVDR框架认证 | https://parsers.vc/news/251219-glycanage-secures-major-funding--reshaping/ |
| 生产基地 | 主要研发实验室位于克罗地亚；在美国加利福尼亚州设有另一实验室；计划在沙特阿拉伯（KACST）设立实验室 | https://agetechworld.co.uk/news/interview-glycanage-launch-first-hospital-based-tests/, https://en.lider.media/2025/12/19/croatian-glycanage-receives-new-investment-of-e8-7-million/, https://parsers.vc/news/251219-glycanage-secures-major-funding--reshaping/, https://www.eu-startups.com/2025/12/uk-longevity-startup-glycanage-raises-e7-4-million-to-bring-glycan-based-ageing-diagnostics-into-mainstream-healthcare/ |

独立来源: agetechworld.co.uk, en.lider.media, eu-startups.com, impetus.capital, parsers.vc

## 技术

- [表观遗传时钟与生物学年龄诊断](https://cn.bioecon.ru/technology/epigenetic-clocks-biological-age-diagnostics/)